FDA Discontinues Methotrexate Sodium Injection (ANDA089309)

The U.S. Food and Drug Administration (FDA) has recorded the methotrexate sodium injection (product number 001) from sponsor Quad Pharms as discontinued. The product is an injectable formulation with a strength of EQ 25 mg base per mL. It is not designated as a reference drug, and its marketing status is listed as discontinued under application number ANDA089309.